Sabuwar na'urar samfurin jini na microfluidic na iya maye gurbin allura da venipuncture a cikin labs na likita

Agusta 17, 2015 |Kayayyaki da kayan aiki, Laboratory kayan aikin da dakin gwaje-gwaje, Labarin dakin gwaje-gwaje, Ayyukan dakin gwaje-gwaje, Laboratory pathology, Laboratory gwajin
Ta hanyar sanya wannan na'ura mara tsadar amfani guda ɗaya, wanda aka haɓaka a Jami'ar Wisconsin-Madison, akan hannu ko cikin ciki, marasa lafiya na iya tattara nasu jinin a gida cikin mintuna kaɗan.
Fiye da shekaru biyu, kafofin watsa labaru na Amurka suna sha'awar ra'ayin Theranos Shugaba Elizabeth Holmes na ba marasa lafiya da ke buƙatar gwajin jini gwajin jini na ɗan yatsa maimakon venipuncture.A halin da ake ciki, dakunan gwaje-gwaje a duk faɗin ƙasar suna aiki don haɓaka hanyoyin tattara samfuran don gwaje-gwajen gwaje-gwajen likitanci waɗanda ba sa buƙatar allura kwata-kwata.
Tare da irin wannan ƙoƙarin, yana iya shiga kasuwa da sauri.Wannan sabuwar na'ura ce mai tarin jini mara allura mai suna HemoLink, wanda wata ƙungiyar bincike a Jami'ar Wisconsin-Madison ta haɓaka.Masu amfani suna sanya na'urar mai girman ƙwallon golf a hannu ko cikin su na mintuna biyu.A wannan lokacin, na'urar tana ɗaukar jini daga capillaries zuwa cikin ƙaramin akwati.Sa'an nan majiyyaci zai aika da bututun jinin da aka tattara zuwa dakin gwaje-gwaje na likita don bincike.
Wannan na'ura mai aminci ya dace da yara.Koyaya, marasa lafiya waɗanda ke buƙatar gwajin jini na yau da kullun don lura da lafiyar su kuma za su amfana yayin da yake ceton su daga tafiye-tafiye akai-akai zuwa ɗakunan gwaje-gwaje na asibiti don jawo jini tare da hanyar allura ta gargajiya.
A cikin wani tsari da ake kira "aiki capillary," HemoLink yana amfani da microfluidics don ƙirƙirar ƙaramin wuri wanda ke jawo jini daga capillaries ta hanyar ƙananan tashoshi a cikin fata zuwa cikin tubules, rahoton Gizmag.Na'urar tana tattara 0.15 cubic centimeters na jini, wanda ya isa ya gano cholesterol, cututtuka, kwayoyin cutar kansa, sukarin jini da sauran yanayi.
Masana ilimin cututtuka da ƙwararrun lab na asibiti za su kalli ƙaddamarwar ƙarshe na HemoLink don ganin yadda masu haɓaka ta ke shawo kan matsalolin da suka shafi daidaiton gwajin dakin gwaje-gwaje wanda zai iya haifar da ruwan tsaka-tsaki wanda galibi yana tare da jinin capillary yayin tattara irin waɗannan samfuran.Yadda fasahar gwajin dakin gwaje-gwaje da Theranos ke amfani da ita za ta iya magance wannan matsala ta kasance abin da aka fi mayar da hankali kan dakin gwaje-gwajen likitanci.
Tasso Inc., farkon likita wanda ya haɓaka HemoLink, an haɗa shi ta hanyar tsoffin masu binciken microfluidics UW-Madison uku:
Casavant ya bayyana dalilin da yasa sojojin microfluidic ke aiki: "A wannan ma'auni, tashin hankali na sama ya fi mahimmanci fiye da nauyi, kuma yana kiyaye jini a cikin tashar komai yadda kuke riƙe na'urar," in ji shi a cikin rahoton Gizmag.
Hukumar Kula da Ayyukan Bincike na Tsaro (DARPA), sashin bincike na Ma'aikatar Tsaro ta Amurka (DOD) ce ta dauki nauyin aikin da dala miliyan 3.
Masu haɗin gwiwa guda uku na Tasso, Inc., tsoffin masu binciken microfluidics a Jami'ar Wisconsin-Madison (daga hagu zuwa dama): Ben Casavant, Mataimakin Shugaban Ayyuka da Injiniya, Erwin Berthier, Mataimakin Shugaban Bincike da Ci gaba da Fasaha, da Ben Moga, Shugaba, a cikin kantin kofi sun yi tunanin HemoLink.(Haƙƙin mallaka na Hoto Tasso, Inc.)
Na'urar HemoLink yana da arha don kerawa kuma Tasso yana fatan samar da ita ga masu amfani a cikin 2016, a cewar Gizmag.Duk da haka, wannan na iya dogara ne akan ko masana kimiyyar Tasso zasu iya samar da wata hanya don tabbatar da kwanciyar hankali na samfurorin jini.
A halin yanzu, yawancin samfuran jini don gwajin dakin gwaje-gwaje na asibiti suna buƙatar jigilar kaya a cikin sarkar sanyi.A cewar rahoton Gizmag, masana kimiyyar Tasso suna son adana samfuran jini a digiri 140 na Fahrenheit na mako guda don tabbatar da cewa an gwada su lokacin da suka isa dakin gwaje-gwaje na asibiti don sarrafawa.Tasso yana shirin neman izinin Hukumar Abinci da Magunguna ta Amurka (FDA) a ƙarshen wannan shekara.
HemoLink, na'urar tattara jinin mara allura mai arha mai arha, na iya samuwa ga masu amfani a cikin 2016. Yana amfani da tsarin da ake kira "capillary action" don jawo jini cikin bututun tarawa.Masu amfani suna sanya shi a hannu ko cikin su na tsawon mintuna biyu, bayan haka ana aika bututun zuwa dakin gwaje-gwaje na likita don bincike.(Haƙƙin mallaka na Hoto Tasso, Inc.)
HemoLink babban labari ne ga mutanen da ba sa son sandunan allura da masu biyan kuɗi waɗanda ke kula da rage farashin kiwon lafiya.Bugu da ƙari, idan Tasso ya yi nasara kuma FDA ta amince da shi, zai iya samar da mutane a duk duniya - har ma a wurare masu nisa - tare da ikon haɗi zuwa ɗakunan gwaje-gwaje na jini na tsakiya da kuma amfana daga ci gaba da bincike.
Modja ya ce "Muna da cikakkun bayanai, ƙungiyar gudanarwa mai ƙarfi da kuma buƙatun asibiti da ba a cika ba a cikin kasuwa mai girma," in ji Modja a cikin rahoton Gizmag."Samar da kulawar gida tare da tarin jini mai aminci da dacewa don ganewar asibiti da kulawa shine nau'in sabon abu wanda zai iya inganta sakamako ba tare da kara farashin kiwon lafiya ba."
Amma ba duk masu ruwa da tsaki a masana'antar dakin gwaje-gwajen likita ba ne za su ji daɗin ƙaddamar da kasuwar HemoLink.Fasaha ce mai yuwuwar canza wasa don duka dakunan gwaje-gwaje na asibiti da kuma kamfanin Silicon Valley Biotech Company Theranos, wanda ya kashe miliyoyin daloli don kammala yadda yake yin hadadden gwajin jini daga samfuran jinin yatsa, in ji rahoton Amurka A YAU.
Zai zama abin ban mamaki idan masu haɓakawa na HemoLink zasu iya warware duk wata matsala tare da fasahar su, samun izinin FDA, kuma su kawo kasuwa a cikin watanni 24 masu zuwa wanda ke kawar da buƙatar ɗaukar hoto da samfurin yatsa.Yawancin gwaje-gwajen dakin gwaje-gwaje na likita.Wannan tabbas zai saci "ƙaramar tsawa" daga Theranos, wanda a cikin shekaru biyu da suka gabata yana nuna hangen nesa don kawo sauyi ga masana'antar gwajin gwaji na asibiti kamar yadda yake aiki a yau.
Theranos Ya Zaɓi Phoenix Metro zuwa Tutar Shuka don Shiga Kasuwancin Gwajin Gwajin Kwayoyin cuta
Shin Theranos zai iya canza kasuwa don gwajin gwajin asibiti?Duban haƙiƙa na ƙarfi, nauyi da ƙalubalen da ya kamata a magance
Ban gane abin da ke faruwa a nan ba.Idan ya jawo jini ta fata, ba ya haifar da wani yanki na jini, wanda ake kira hickey?Fatar jiki ce mai avascular, to yaya ake yi?Shin akwai wanda zai iya bayyana wasu hujjojin kimiyya a bayan wannan?Ina tsammanin babban ra'ayi ne… amma ina son ƙarin sani.Godiya
Ban tabbata yadda wannan a zahiri ke aiki ba - Theranos baya fitar da bayanai da yawa.A cikin 'yan kwanakin da suka gabata, sun kuma sami sanarwar tsagaitawa da kuma daina sanarwa.Fahimtar da nake da ita game da waɗannan na'urori shine cewa suna amfani da "kumburi" masu yawa na capillaries waɗanda suke aiki kamar allura.Za su iya barin faci kaɗan kaɗan, amma ba na tsammanin shigar da fata gabaɗaya ta yi zurfi kamar allura (misali Akkuchek).


Lokacin aikawa: Mayu-25-2023
  • wechat
  • wechat